March 20, 2023 3:44 PM
Latest:
  • Jim Cramer Calls For First Republic Bank To Be Placed Into Receivership
  • Credit Suisse: Bondholders Left Empty-Handed While Equity Holders Get Paid
  • BC, Ontario Taxes Rumored To Approach 60% In New Budget
  • The Fed’s Balance Sheet Is Overstated — With Tavi Costa
  • Amazon Preparing To Lay Off Another 9,000 Workers
The Deep Dive

the deep dive

Providing stock analysis for investors of the Canadian junior markets

Thank you!

You have successfully joined our subscriber list.

.

  • Home
  • Latest
    • Automotive
    • Briefing
    • Cannabis
    • Commentary
    • Education
    • Full Analysis
    • Gold
    • Industrials
    • Macro
    • Oil
    • Psychedelics
    • Resources
    • Technology
  • Cannabis
  • Technology
  • Company Profiles
    • Hemlo Explorers
    • HydroGraph Clean Power
    • Power Nickel
    • Prime Meridian Resources
    • Riverside Resources
    • RooGold Inc
    • Slave Lake Zinc
    • Spey Resources
    • Trillion Energy
    • Vortex Metals
  • Resources
  • About
  • Contact Us
  • Advertise With Us

Psilocybin

Briefing Healthcare 

Australia Becomes First to Reclassify MDMA and Psilocybin As Medicine for Specific Uses

February 13, 2023 3:47 PMFebruary 13, 2023 12:35 PM JP Alegre 0 Comments Australia, MDMA, Psilocybin

Australia has become the first country in the world to re-classify the psychedelic substances psilocybin and MDMA (3,4-methylenedioxy-methamphetamine) as medicines.

Share
Tweet
Share
Read more
Briefing Healthcare Psychedelics 

Quebec Makes History As First Province in Canada to Cover Psilocybin-Assisted Psychotherapy

December 21, 2022 12:48 PMDecember 21, 2022 12:42 PM JP Alegre 0 Comments Psilocybin, Quebec

Last week, Quebec became the first governing medical body in Canada to publicly fund medical psilocybin-assisted psychotherapy, with advocates hoping

Share
Tweet
Share
Read more
Briefing News Psychedelics 

Revive Therapeutics Provides Update On Current Psilocybin Programs

August 10, 2021 8:36 AMAugust 10, 2021 8:36 AM Jay Lutz 0 Comments Psilocybin, Revive Therapeutics

Revive Therapeutics (CSE: RVV) this morning provided a corporate update as it pertains to its psychedelic assets. The update primarily

Share
Tweet
Share
Read more
Briefing Psychedelics 

Compass Pathways Closes Enrollment For Phase IIb Psilocybin Clinical Trial

June 28, 2021 7:37 AMJune 28, 2021 7:37 AM Jay Lutz 0 Comments Compass Pathways, Psilocybin

Compass Pathways (NASDAQ: CMPS) this morning provided a brief update to the market on the latest status of its ongoing

Share
Tweet
Share
Read more
Briefing Psychedelics 

Numinus Wellness To Undertake Phase 1 Study Of Psilocybin Extract

April 26, 2021 7:10 AMApril 26, 2021 7:10 AM Jay Lutz 0 Comments Numinus Wellness Inc, Psilocybin

Numinus Wellness (TSXV: NUMI) is undertaking further studies of its psilocybin products. The company this morning announced a partnership with

Share
Tweet
Share
Read more
Briefing News Psychedelics 

Revive Therapeutics Files For Patent On Oral Thin Film With Psilocybin

April 22, 2021 8:18 AMApril 22, 2021 8:19 AM Jay Lutz 0 Comments Psilocybin, Revive Therapeutics

Revive Therapeutics (CSE: RVV) this morning announced that it has successfully completed research on an oral thin film delivery system

Share
Tweet
Share
Read more
Briefing News Psychedelics 

Revive Therapeutics Enters LOI To Acquire Psilocybin Program From PharmaTher

December 21, 2020 8:38 AMDecember 21, 2020 9:11 AM Jay Lutz 0 Comments Pharmather, Psilocybin, Revive Therapeutics

Revive Therapeutics (CSE: RVV) this morning announced that it has entered into a letter of intent to acquire PharmaTher Inc’s

Share
Tweet
Share
Read more
Briefing Psychedelics 

Growing Medical Acceptance of Psychedelics – The Daily Dive feat Derek Welsh of Revive Therapeutics

December 4, 2020 1:00 PMDecember 4, 2020 12:45 PM Jay Lutz 0 Comments Psilocybin, Revive Therapeutics

For our final episode of The Daily Dive this week, host Cassandra Leah is joined by that of Derek Welsh

Share
Tweet
Share
Read more
Briefing News Psychedelics 

Revive Therapeutics Completes Psilocybin Oral Thin Film Strip Product

November 11, 2020 9:35 AMNovember 11, 2020 9:36 AM Jay Lutz 0 Comments Psilocybin, Revive Therapeutics

Revive Therapeutics (CSE: RVV) has completed its oral thin film strip product for psilocybin after several months of prototyping. The

Share
Tweet
Share
Read more
Briefing Cannabis Full Analysis Psychedelics 

Parallels of Psychedelic Mushrooms and Cannabis

March 5, 2020 10:00 AMMarch 5, 2020 10:00 AM Harvest Moon Research Harvest Moon Research, Psilocybin

Psychedelics are a class of pharmacological compounds that produce unique and profound changes of consciousness. The most common psychedelics are

Share
Tweet
Share
Read more
  • ← Previous

Briefings

Jim Cramer Calls For First Republic Bank To Be Placed Into Receivership
Briefing Macro 

Jim Cramer Calls For First Republic Bank To Be Placed Into Receivership

March 20, 2023 3:08 PM Jay Lutz 0

Jim Cramer is looking for solutions to calm the ongoing financial sector crisis, with his latest call being to ringfence

Credit Suisse: Bondholders Left Empty-Handed While Equity Holders Get Paid
Briefing Macro 

Credit Suisse: Bondholders Left Empty-Handed While Equity Holders Get Paid

March 20, 2023 3:03 PM Jim McFadden 0
BC, Ontario Taxes Rumored To Approach 60% In New Budget
Briefing Macro 

BC, Ontario Taxes Rumored To Approach 60% In New Budget

March 20, 2023 2:24 PM ER Velasco 0
The Fed’s Balance Sheet Is Overstated — With Tavi Costa
Briefing Macro Video Series 

The Fed’s Balance Sheet Is Overstated — With Tavi Costa

March 20, 2023 1:30 PM Jay Lutz 0
Amazon Preparing To Lay Off Another 9,000 Workers
Briefing Macro Technology 

Amazon Preparing To Lay Off Another 9,000 Workers

March 20, 2023 1:14 PM Hermina Paull 0
Russia’s Wagner Group Suspected of Gunning Down Chinese Nationals at African Gold Mine
Briefing Politics Resources 

Russia’s Wagner Group Suspected of Gunning Down Chinese Nationals at African Gold Mine

March 20, 2023 12:40 PM Hermina Paull 0
David Sacks vs. Marc Cohodes, Explained
Briefing Macro 

David Sacks vs. Marc Cohodes, Explained

March 20, 2023 11:41 AM ER Velasco 0

Spotlight Series

The Fed’s Balance Sheet Is Overstated — With Tavi Costa
Briefing Macro Video Series 

The Fed’s Balance Sheet Is Overstated — With Tavi Costa

March 20, 2023 1:30 PM Jay Lutz 0

The Daily Dive opens this week with regular guest Tavi Costa, Partner & Portfolio Manager for Crescat Capital. Tavi joins

News

First Phosphate Recovers 91.4% Of Apatite In Metallurgy Tests, Produces 40.2% P2O5 Concentrate
Briefing News Resources 

First Phosphate Recovers 91.4% Of Apatite In Metallurgy Tests, Produces 40.2% P2O5 Concentrate

March 20, 2023 9:28 AM Jay Lutz 0

Early metallurgy results are in for First Phosphate (CSE: PHOS) in conjunction with an ongoing preliminary economic assessment being conducted

Eguana Sees ITOCHU Increase Stake To 12.95%
Briefing News Technology 

Eguana Sees ITOCHU Increase Stake To 12.95%

March 16, 2023 9:00 AM Jay Lutz 0
Carlyle Commodities Hits 689 Metres Of 0.51 g/t Gold
Briefing News Resources 

Carlyle Commodities Hits 689 Metres Of 0.51 g/t Gold

March 15, 2023 10:06 AM Jay Lutz 0
First Phosphate: New Report Suggests Flagship Property Holds ESG-Compliant Source Of Phosphate For LFP Battery Industry
Briefing News Resources 

First Phosphate: New Report Suggests Flagship Property Holds ESG-Compliant Source Of Phosphate For LFP Battery Industry

March 14, 2023 11:22 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Menu

  • Home
  • About
  • Research
  • Discover
  • Contact Us
  • Disclaimer

Categories

  • Automotive
  • Biotech
  • Blockchain
  • Bonds
  • Briefing
  • Cannabis
  • Commentary
  • Education
  • Energy
  • Entertainment
  • Esports
  • ETFs
  • Food
  • Full Analysis
  • Healthcare
  • Industrials
  • Lithium
  • Macro
  • Market Movers
  • Mental Hurdles
  • News
  • Oil
  • Politics
  • Psychedelics
  • Real Estate
  • Resources
  • Retail
  • SPACs
  • Technology
  • Video Series
Copyright © 2023 the deep dive. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.